CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
Original article

{"a":[{"_":"Fresenius pulls one batch of Actemra biosim over glass particle concerns","$":{"href":"/pharma/fresenius-pulls-one-batch-actemra-biosim-over-glass-particle-concerns","hreflang":"en"}}]}

RegulatoryActemra biosimNegative
AI Analysis

Summary

Fresenius Kabi is recalling a batch of Actemra biosim in the U.S. due to glass particle concerns, following a separate recall of mislabeled pain medicine.

Outcome Details

Batch recall due to glass particle concerns

Importance:4/10
Sentiment:
-0.70
product recallsafety concernglass particlesbiosimilarmanufacturing issue
Related Companies

Read the original article

Published by FiercePharma on August 12, 2026 8:42 AM

Read Original